Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 8/20 | 0.69 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.65 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9765885 | 0.82 | ADORA2B (1.00) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 | |
| SCHEMBL1944674 | 0.80 | ADORA2B (0.74) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL1497239 | 0.79 | ALDH1A1 (0.49) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 | |
| 8-Phenyl Theophylline SCHEMBL516432 | 0.79 | ADORA2A (1.00) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 | |
| SCHEMBL7058942 | 0.77 | ADORA2B (0.56) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 | |
| SCHEMBL515920 | 0.76 | ADORA2B (1.00) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 | |
| SCHEMBL20656214 | 0.74 | KDM4E (0.53) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 | |
| SCHEMBL7057695 | 0.74 | KDM4E (0.62) | ADORA2BADORA2AKDM4EHSD17B10NPSR1 | |
| SCHEMBL18990066 | 0.73 | KMT2A (0.51) | KDM4EHSD17B10NPSR1KMT2AALDH1A1 | |
| SCHEMBL13977442 | 0.73 | ADORA2B (0.61) | ADORA2BADORA2AKDM4EHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1372411-A1 | LOW GLYCEMIC RESPONSE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2004-01-02 | — | — | EP | disclosed |
| EP-1322184-A2 | BEVERAGE COMPOSITIONS COMPRISING ARABINOGALACTAN AND DEFINED VITAMINS | THE PROCTER & GAMBLE COMPANY (US) | 2003-07-02 | — | — | EP | disclosed |
| EP-1322185-A2 | BEVERAGE COMPOSITIONS COMPRISING ARABINOGALACTAN AND MINERAL SUPPLEMENT | THE PROCTER & GAMBLE COMPANY (US) | 2003-07-02 | — | — | EP | disclosed |
| EP-1289532-A2 | LOW CARBOHYDRATE COMPOSITIONS, KITS THEREOF, AND METHODS OF USE | The Procter & Gamble Company (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-1289510-A2 | COMPOSITIONS, KITS, AND METHODS FOR PROMOTING DEFINED HEALTH BENEFITS | THE PROCTER & GAMBLE COMPANY (US) | 2003-03-12 | — | — | EP | disclosed |
| WO-2002078469-A1 | LOW GLYCEMIC RESPONSE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-10-10 | — | — | WO | disclosed |
| WO-2002052959-A2 | BEVERAGE COMPOSITIONS COMPRISING PALATABLE CALCIUM AND MAGNESIUM SOURCES | THE PROCTER & GAMBLE COMPANY (US) | 2002-07-11 | — | — | WO | disclosed |
| WO-2002026055-A2 | BEVERAGE COMPOSITIONS COMPRISING ARABINOGALACTAN AND DEFINED VITAMINS | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-04 | — | — | WO | disclosed |
| WO-2002026053-A2 | BEVERAGE COMPOSITIONS COMPRISING ARABINOGALACTAN AND MINERAL SUPPLEMENT | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-04 | — | — | WO | disclosed |
| WO-2001093831-A2 | LOW CARBOHYDRATE COMPOSITIONS, KITS THEREOF, AND METHODS OF USE | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001093847-A2 | COMPOSITIONS, KITS, AND METHODS FOR PROMOTING DEFINED HEALTH BENEFITS | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |